ICU Medical ICUI Infusion Systems — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ICU Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ICU Medical's infusion systems — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ICU Medical's infusion systems — revenue?
- ICU Medical (ICUI) reported infusion systems — revenue of $179.6M in Q1 2026.
- How has ICU Medical's infusion systems — revenue changed year-over-year?
- ICU Medical's infusion systems — revenue increased by 8.0% year-over-year, from $166.3M to $179.6M.
- What is the long-term trend for ICU Medical's infusion systems — revenue?
- Over 4 years (2021 to 2025), ICU Medical's infusion systems — revenue has grown at a 18.0% compound annual growth rate (CAGR), from $352.32M to $684.21M.
- What does infusion systems — revenue mean?
- This metric represents the total gross sales generated from the infusion systems product line, which includes hardware, software, and integrated pump systems used for intravenous therapy. It serves as a primary indicator of the company's market penetration and demand for its core capital equipment and associated technology platforms. Tracking this revenue stream helps investors assess the growth trajectory of the company's specialized medical device portfolio.